Neutralizing antibodies against COVID-19 in healthcare workers vaccinated (with or without a heterologous booster dose) to evaluate the vaccine breakthrough infection in Peru

Published: 29 September 2022| Version 2 | DOI: 10.17632/3rx5mhntmp.2
Jose Alonso Caceres Del Aguila


This database was built with secondary information from healthcare workers in a private laboratory in Lima, Peru. This database is part of cohort research that evaluated the association between the neutralizing antibody levels as a protective factor against vaccine breakthrough infection in healthcare workers during the third COVID-19 wave in Peru.



Enzyme-Linked Immunosorbent Assay, Neutralizing Antibody, Laboratory Diagnosis, Healthcare Research, Peru, Immunodiagnosis, Vaccination, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, Pandemic